Quest Diagnostics Incorporated Financial Statements (DGX)
|
|
|
|
Report date
|
|
|
22.02.2021 |
28.02.2022 |
31.12.2022 |
21.02.2023 |
22.02.2024 |
|
23.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
9 437 |
10 788 |
9 883 |
9 883 |
9 252 |
|
9 770 |
|
Operating Income, bln rub |
|
|
1 971 |
2 381 |
1 428 |
1 428 |
1 262 |
|
1 351 |
|
EBITDA, bln rub |
? |
|
2 411 |
3 159 |
1 785 |
1 820 |
1 732 |
|
1 143 |
|
Net profit, bln rub |
? |
|
1 431 |
1 995 |
946.0 |
946.0 |
854.0 |
|
1 325 |
|
|
OCF, bln rub |
? |
|
2 005 |
2 233 |
1 718 |
1 718 |
1 272 |
|
1 072 |
|
CAPEX, bln rub |
? |
|
418.0 |
403.0 |
404.0 |
404.0 |
408.0 |
|
394.0 |
|
FCF, bln rub |
? |
|
1 587 |
1 830 |
1 314 |
1 314 |
864.0 |
|
1 070 |
|
Dividend payout, bln rub
|
|
|
297.0 |
309.0 |
305.0 |
305.0 |
314.0 |
|
252.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
20.8% |
15.5% |
32.2% |
32.2% |
36.8% |
|
19.0% |
|
|
OPEX, bln rub |
|
|
1 662 |
1 828 |
1 874 |
2 005 |
1 610 |
|
1 765 |
|
Cost of production, bln rub |
|
|
5 804 |
6 579 |
0.000 |
6 450 |
6 291 |
|
8 123 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
163.0 |
151.0 |
138.0 |
138.0 |
163.0 |
|
381.0 |
|
|
Assets, bln rub |
|
|
14 026 |
13 611 |
12 837 |
12 837 |
14 022 |
|
16 095 |
|
Net Assets, bln rub |
? |
|
6 759 |
6 444 |
5 893 |
5 893 |
6 307 |
|
6 809 |
|
Debt, bln rub |
|
|
4 655 |
4 657 |
4 775 |
4 622 |
5 369 |
|
6 970 |
|
Cash, bln rub |
|
|
1 158 |
872.0 |
315.0 |
315.0 |
686.0 |
|
764.0 |
|
Net debt, bln rub |
|
|
3 497 |
3 785 |
4 460 |
4 307 |
4 683 |
|
6 206 |
|
|
Ordinary share price, rub |
|
|
119.2 |
173.0 |
156.4 |
156.4 |
137.9 |
|
131.3 |
|
Number of ordinary shares, mln |
|
|
134.0 |
125.0 |
116.0 |
116.0 |
112.0 |
|
112.0 |
|
|
Market cap, bln rub |
|
|
15 969 |
21 626 |
18 147 |
18 147 |
15 443 |
|
14 709 |
|
EV, bln rub |
? |
|
19 466 |
25 411 |
22 607 |
22 454 |
20 126 |
|
20 915 |
|
Book value, bln rub |
|
|
-1 281 |
-1 818 |
-2 419 |
-2 419 |
-2 592 |
|
-3 512 |
|
|
EPS, rub |
? |
|
10.7 |
16.0 |
8.16 |
8.16 |
7.63 |
|
11.8 |
|
FCF/share, rub |
|
|
11.8 |
14.6 |
11.3 |
11.3 |
7.71 |
|
9.55 |
|
BV/share, rub |
|
|
-9.56 |
-14.5 |
-20.9 |
-20.9 |
-23.1 |
|
-31.4 |
|
|
EBITDA margin, % |
? |
|
25.5% |
29.3% |
18.1% |
18.4% |
18.7% |
|
11.7% |
|
Net margin, % |
? |
|
15.2% |
18.5% |
9.57% |
9.57% |
9.23% |
|
13.6% |
|
FCF yield, % |
? |
|
9.94% |
8.46% |
7.24% |
7.24% |
5.59% |
|
7.27% |
|
ROE, % |
? |
|
21.2% |
31.0% |
16.1% |
16.1% |
13.5% |
|
19.5% |
|
ROA, % |
? |
|
10.2% |
14.7% |
7.37% |
7.37% |
6.09% |
|
8.23% |
|
|
P/E |
? |
|
11.2 |
10.8 |
19.2 |
19.2 |
18.1 |
|
11.1 |
|
P/FCF |
|
|
10.1 |
11.8 |
13.8 |
13.8 |
17.9 |
|
13.7 |
|
P/S |
? |
|
1.69 |
2.00 |
1.84 |
1.84 |
1.67 |
|
1.51 |
|
P/BV |
? |
|
-12.5 |
-11.9 |
-7.50 |
-7.50 |
-5.96 |
|
-4.19 |
|
EV/EBITDA |
? |
|
8.07 |
8.04 |
12.7 |
12.3 |
11.6 |
|
18.3 |
|
Debt/EBITDA |
|
|
1.45 |
1.20 |
2.50 |
2.37 |
2.70 |
|
5.43 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
4.43% |
3.74% |
4.09% |
4.09% |
4.41% |
|
4.03% |
|
| Quest Diagnostics Incorporated shareholders |
